x

Accedi

x

Sign Up


Registrati

CAPRELSA® (vandetanib) REMS Program | Advanced Medullary Thyroid Carcinoma (MTC)

Information for the CAPRELSA REMS Program. CAPRELSA® (vandetanib), a kinase inhibitor, approved by the FDA for symptomatic or progressive medullary thyroid cancer treatment in patients with unresectable locally advanced or metastatic disease.
E il tuo sito? Certifica il tuo sito e aggiorna le informazioni

CAPRELSATOUCHPOINTS.COM on social networks



WHOIS
Add To Favorites

Siti relativi

Cut the Rope 2
Cut the Rope 2
Tap The Frog
Tap The Frog
FRUIT SLOTS
FRUIT SLOTS
MEGA SLOTS
MEGA SLOTS
1941 FROZEN FRONT
1941 FROZEN FRONT
Cut the Rope
Cut the Rope